Transparency Life Sciences

changing the paradigm of drug development

Friday, February 11, 2011

Transparency LS in the news: FierceBiotechIT

http://www.fiercebiotechit.com/story/open-rd-challenges-big-pharma-innovation/2011-02-10


Open R&D challenges big pharma innovation

February 10, 2011 — 6:13pm ET | By George Miller


Read more: Open R&D challenges big pharma innovation - FierceBiotechIT http://www.fiercebiotechit.com/story/open-rd-challenges-big-pharma-innovation/2011-02-10#ixzz1Di5tnWMy
Subscribe: http://www.fiercebiotechit.com/signup?sourceform=Viral-Tynt-FierceBiotechIT-FierceBiotechIT
Posted by Tomasz Sablinski at 7:05 PM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

Wednesday, February 9, 2011

Please respect FT.com's ts&cs and copyright policy which allow you to: share links; copy content for personal use; & rs or use this link to reference the article - http://www.ft.com/cms/s/0/6b2e1aFina "The future of pharma will probably look more like the peer-reviewed open process....

http://www.ft.com/cms/s/0/6b2e1aa6-33d6-11e0-b1ed-00144feabdc0.html?ftcamp=crm/email/201129/nbe/DrugsHealthcare/product#axzz1DSr7xvtx

wouldn't you agree?
Posted by Tomasz Sablinski at 10:56 AM No comments:
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Followers

Blog Archive

  • ►  2010 (14)
    • ►  December (14)
  • ▼  2011 (19)
    • ►  January (2)
    • ▼  February (2)
      • Please respect FT.com's ts&cs and copyright policy...
      • Transparency LS in the news: FierceBiotechIT
    • ►  March (1)
    • ►  April (3)
    • ►  June (1)
    • ►  July (4)
    • ►  August (1)
    • ►  September (4)
    • ►  November (1)

About Me

Tomasz Sablinski
Passionate about changing the paradigm of drug development by converging modern information technology with drug development "know-how", and exploiting an unlimited potential of "knowledge networking" to revolutionize drug development and therapeutic decisions. Over thirty years of experience in healthcare ranging from basic research through clinical practice to drug and biologics development, in a broad international setting of Europe, Japan, and US.
View my complete profile

Total Pageviews

TLS. Simple theme. Powered by Blogger.